[1] HAN B, ZHENG R, ZENG H, et al.Cancer incidence and mortality in China, 2022[J]. Zhonghua Zhong Liu Za Zhi, 2024,46(3):221-231. [2] CARRILHO F J, PARANAGUÁ-VEZOZZO D C, CHAGAS A L, et al. Epidemiology of liver cancer in latin america: current and future trends[J]. Semin Liver Dis, 2020,40(2):101-110. [3] 曹毛毛,李贺,孙殿钦,等.全球肝癌2020年流行病学现状[J].中华肿瘤防治杂志, 2022,29(5):322-328. [4] 曹毛毛,杨帆,李倩茹,等.中日韩肝癌流行病学分布对比分析[J].中华肿瘤防治杂志, 2024,31(4):205-209. [5] ZENG Q A, QIU J, ZOU R, et al.Clinical features and outcome of multiple primary malignancies involving hepatocellular carcinoma: a long-term follow-up study[J]. BMC Cancer, 2012,12:148. [6] 孙培伟,白雪莉,陈义刚,等.合并肝细胞癌多原发癌临床特点(附25例报告)[J].中国实用外科杂志, 2017,37(3):281-283. [7] HONG S, JEONG S H, LEE S S, et al.Prevalence and outcomes of extrahepatic primary malignancy associated with hepatocellular carcinoma in a Korean population[J]. BMC Cancer, 2015,15:146. [8] SHIMADA M, TAKENAKA K, FUJIWARA Y, et al.Characteristics of hepatocellular carcinoma associated with extrahepatic primary malignancies in southern Japan[J]. Am J Gastroenterol, 1996,91(4):754-758. [9] FERNÁNDEZ-RUIZ M, GUERRA-VALES J M, CASTELBÓN-FERNÁNDEZ F J, et al. Multiple primary malignancies in Spanish patients with hepatocellular carcinoma: analysis of a hospital-based tumor registry[J]. J Gastroenterol Hepatol, 2009,24(8):1424-1430. [10] NZEAKO U C, GOODMAN Z D, ISHAK K G.Association of hepatocellular carcinoma in North American patients with extrahepatic primary malignancies[J]. Cancer, 1994,74(10):2765-2771. [11] SUPRAMANIAM R.New malignancies among cancer survivors: SEER cancer registries, 1973-2000[J]. J Epidemiol Commun Health, 2008,62(4):375-376. [12] 中国抗癌协会多原发和不明原发肿瘤专业委员会.中国抗癌协会多原发和不明原发肿瘤诊治指南(2023年版)[J].中国癌症杂志, 2023,33(4):403-422. [13] AKIHISA H, NORIE S, THOMAS S, et al.Family history of cancer and subsequent risk of cancer: a large- scale population-based prospective study in Japan[J]. Int J Cancer, 2019, 147(2):331-337. [14] BYCHKOVSKY B L, LO M T, YUSSUF a, et al. Prevalence and spectrum of pathogenic variants among patients with multiple primary cancers evaluated by clinical characteristics[J]. Cancer, 2022,128(6):1275-1283. [15] VALDEZ R, YOON P W, QURESHI N, et al.Family history in public health practice: a genomic tool for disease prevention and health promotion[J]. Annu Rev Public Health, 2010,31:69-87. [16] 李一杰,黄创新,肖妹,等.肝外恶性肿瘤对合并肝癌的多原发癌患者生存影响的Meta分析[J/CD].中华普通外科学文献(电子版), 2014,8(5):408-411. [17] 李一杰,朱伟平,罗世坚,等.中国270例合并肝细胞癌的多原发癌个体数据Meta分析[J/CD].中华肝脏外科手术学电子杂志, 2017,6(1):40-44. |